Clinical Evaluation of GRAPE Model for Gastric Cancer Screening

Zhejiang Cancer Hospital1,000,000 enrolled

Overview

A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages

Study Type

OBSERVATIONAL

Enrollment

1,000,000

Conditions

Gastric Cancer

Interventions

Results following systematic screeningDIAGNOSTIC_TEST

The GRAPE model's output (positive or negative) determines whether patients require follow-up gastroscopy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Aged between 18 and 80 years * Individuals undergoing thoracoabdominal CT examination * Voluntarily participated in the study and provided written informed consent Exclusion Criteria: * Patients with confirmed diagnosis of gastric cancer * Individuals with severe intellectual disabilities or communication disorders

Locations (1)

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)

Hangzhou, Zhejiang, China

RECRUITING

Outcomes

Primary Outcomes

GRAPE systematic screening results

Screen-positive individuals after GRAPE systematic screening

Time frame: first visited at baseline

Central Contacts

Xiangdong Cheng

CONTACT

0086-571-881280 chengxd@zjcc.org.cn

Can Hu

CONTACT

13968032995 chengxd@zjcc.org.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.